acarbose, a novel drug for type II, or non-insulin-dependent, diabetes

Bayer is now launching acarbose, a novel drug for type II, or non-insulin-dependent, diabetes. ...

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote